Slide 1: Conference Call Presentation Q3-26
Conference Call Presentation Q3-26 For the quarter ended June 30, 2026
Slide 2: Caution Regarding Forward Looking Statements
Caution Regarding Forward Looking Statements Certain information included in this document is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally ac
Slide 3: Q3-26 Highlights
Q3-26 Highlights Record Q3 results & strategic transactions Results Signings & Backlog Strategic Transactions Q3 Revenue/Organic Growth YTD Contract Signings 15-year UK contract + 20%/+16% $660M Q3 adj. EBITDA¹ Pro-forma Backlog Agreement to acquire + 35% ~$1.6B Galaxy 1) This is a non-GAAP measure.
Slide 4: Defence & Space
Defence & Space Continues to perform exceptionally well Q3 Revenue Q3 adj. EBITDA1 Q3 adj. EBITDA1 % + 20% + 25% ~22% ▪ Announced 15-year contract with Raytheon UK for ~$300M ▪ Agreement to acquire Galaxy Broadband Communications for $24M upfront ▪ Launched ATHORATM, announced collaboration with Coh
Slide 5: Essential Industries
Essential Industries Continues to build meaningful positive momentum Q3 Revenue Q3 adj. EBITDA1 Q3 adj. EBITDA1 % + 20% + 46% ~8% ▪ Organic growth reached double-digits, a steady improvement since the beginning of the year ▪ First nine months of FY26 revenue are up 21% and adj. EBITDA1 is up 59% ▪ P
Slide 6: Q3-26 KPIs - Revenue & Adj. EBITDA
Q3-26 KPIs - Revenue & Adj. EBITDA1 Adj. EBITDA1 growth significantly outpaced revenue growth Revenues Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) 35.0 230 192 22.0% 20% 30.0 25.6 25.0 35% Generated organic 17.0% 20.0 19.0 15.0 11.1% 12.0% growth of +16% 10.0 9.9% 7.0
Slide 7: Q3-26 KPIs - Operating FCF & Capital Deployment
Q3-26 KPIs – Operating FCF & Capital Deployment Capital deployment priority remains acquisitions Operating FCF1 & Conversion Operating FCF1 & Conversion (in millions of $, except ratio) (in millions of $, except ratio) 20 60 55 18 160% 160% 18 50 140% 16 140% 57% 14 46% 120% 12 40 120% 35 12 100% 10
Slide 8: Q3-26 KPIs - Leverage and Cash Availability
Q3-26 KPIs – Leverage and Cash Availability Financial flexibility to act on near-term opportunities Net debt1/adj. EBITDA1 Ratio 1.1x 0.9x Grow working capital in line with revenue growth Q4-25 Q3-26 1) This is a non-GAAP measure. Please refer to the MD&A. © 2026 Calian Group Ltd. 8
Slide 9: FY26 Outlook
FY26 Outlook On track for a record year Mid/Long Term FY26 Revenue Growth Revenue Growth Target 10-15% On track Mid-teens Adj. EBITDA1 Growth Adj. EBITDA1 Growth Target > revenue growth Ahead Low 20% 1) This is a non-GAAP measure. Please refer to the MD&A. © 2026 Calian Group Ltd. 9
Slide 10: Closing Remarks
Closing Remarks Need to invest ahead of the curve YTD Revenue YTD Operating FCF1 YTD Contract Signings + 17% + 57% $660M YTD adj. EBITDA1 Net debt/adj. EBITDA1 Pro forma Backlog + 41% 0.9x ~$1.6B 1) This is a non-GAAP measure. Please refer to the MD&A. © 2026 Calian Group Ltd. 10
Slide 11: Question Period
Question Period Patrick Will Jennifer Houston Majic McCaughey CEO Acting CFO Director, Investor Relations © 2026 Calian Group Ltd. | 11
Slide 12: Appendix A - Reconciliation of Non-GAAP measures
Appendix A – Reconciliation of Non-GAAP measures © 2026 Calian Group Ltd. | 12
Slide 13: Reconciliation of Non-GAAP Measures - Adj. EBITDA
Reconciliation of Non-GAAP Measures – Adj. EBITDA Three months ended Nine months ended (in thousands of $) June 30, 2026 June 30, 2025 June 30, 2026 June 30, 2025 Net profit (loss) $5,941 $590 $17,753 ($91) Share-based compensation 1,654 1,354 4,487 3,394 Restructuring and other 790 1,414 3,252 2,47
Slide 14: Reconciliation of Non-GAAP Measures - Adj. Net Profit
Reconciliation of Non-GAAP Measures – Adj. Net Profit Three months ended Nine months ended (in thousands of $, except # shares and per share amounts) June 30, 2026 June 30, 2025 June 30, 2026 June 30, 2025 Net profit (loss) $5,941 $590 $17,753 ($91) Share-based compensation 1,654 1,354 4,487 3,394 R
Slide 15: Reconciliation of Non-GAAP Measures - Operating FCF
Reconciliation of Non-GAAP Measures – Operating FCF Three months ended Nine months ended (in thousands of $, except per share amounts and %) June 30, 2026 June 30, 2025 June 30, 2026 June 30, 2025 Cash flows generated from operating activities $23,540 24,786 $31,629 $39,028 (free cash flow) M&A cost
Slide 16: Reconciliation of Non-GAAP Measures - Net Debt/Adj. EBITDA
Reconciliation of Non-GAAP Measures – Net Debt/Adj. EBITDA (in thousands of $, except ratio) June 30 2026 June 30, 2025 Cash $46,335 $58,013 Debt facility 141,250 141,000 Net debt (net cash) 94,915 82,987 Trailing twelve month adjusted EBITDA 100,515 77,938 Net debt to adjusted EBITDA 0.9x 1.1x © 20
Slide 17: Thank you
Thank you Jennifer McCaughey, CFA, F.CIRI Director, Investor Relations ir@calian.com